Benefits and limitations of breastfeeding for mothers with malignant tumors
- Authors: Ladodo O.B.1, Iurova M.V.1,2, Khokhlova S.V.1,3, Rodionov V.V.1, Sheshko E.L.4, Zubkov V.V.1,2, Makieva M.I.1, Chutkova D.A.1, Akhapkina E.S.1, Degtyarev D.N.1,2
-
Affiliations:
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Sechenov First Moscow State Medical University (Sechenov University)
- Russian Medical Academy of Continuous Professional Education
- Ministry of Health of the Russian Federation
- Issue: Vol 26, No 1 (2024)
- Pages: 73-79
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/258576
- DOI: https://doi.org/10.26442/18151434.2024.1.202571
- ID: 258576
Cite item
Full Text
Abstract
In the modern world breastfeeding (BF) is considered as a significant factor in reducing the risk of developing malignant tumors of the mammary gland and ovaries. However, the problem of maintenance or refusing BF in malignant neoplasms (malignant neoplasms) still remains open. In recent years, there has been a steady increase in breast cancer (BC), especially in developed countries, with more than 10% of all breast malignancies (BC) diagnosed in women under 40 years of age. The presented article highlights aspects of maintaining lactation in different periods of the relevance of BF in relation to the timing of manifestation of cancer, and also presents data from the multicenter study POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer) on the possibilities of implementing reproductive function and BF in women receiving therapy for hormone-receptor positive (HR+) BC stages I–III. BF with cancer detected in the postpartum period depends on the treatment of the underlying disease. In patients undergoing surgical treatment, BF is not contraindicated, but it is not always technically possible. During chemotherapy, BF is not recommended. When carrying out radiotherapy, it is possible to undergo BF using a healthy mammary gland. There is currently no evidence to suggest that BF woman diagnosed with cancer may have any negative effects. In general, it has been shown that preserving and maintaining lactation in women with a history of cancer is safe for both mother and child.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga B. Ladodo
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: o_ladodo@oparina4.ru
ORCID iD: 0000-0002-4720-7231
Cand. Sci. (Med.)
Russian Federation, МоскваMariia V. Iurova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Sechenov First Moscow State Medical University (Sechenov University)
Email: m_yurova@oparina4.ru
ORCID iD: 0000-0002-0179-7635
Cand. Sci. (Med.), obstetrician-gynecologist, oncologist
Russian Federation, Moscow; MoscowSvetlana V. Khokhlova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Russian Medical Academy of Continuous Professional Education
Email: s_hohlova@oparina4.ru
ORCID iD: 0000-0002-4121-7228
D. Sci. (Med.), Department Head, oncologist
Russian Federation, Moscow; MoscowValerii V. Rodionov
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: dr.valery.rodionov@gmail.com
ORCID iD: 0000-0003-0096-7126
D. Sci. (Med.), Prof.
Russian Federation, MoscowElena L. Sheshko
Ministry of Health of the Russian Federation
Email: sheshkoel@minzdrav.gov.ru
ORCID iD: 0000-0002-8105-3109
Cand. Sci. (Med.), Assoc. Prof.
Russian Federation, MoscowViktor V. Zubkov
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Sechenov First Moscow State Medical University (Sechenov University)
Email: zubkov_v_v@staff.sechenov.ru
ORCID iD: 0000-0002-9697-9596
Sci. (Med.), neonatologist
Russian Federation, Moscow; MoscowMziya I. Makieva
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: m_makieva@oparina4.ru
ORCID iD: 0000-0002-2632-4666
Cand. Sci. (Med.), Department Head, neonatologist
Russian Federation, MoscowDar’ia A. Chutkova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Author for correspondence.
Email: huhreva@gmail.com
ORCID iD: 0000-0002-0356-1220
Leading Specialist
Russian Federation, MoscowElena S. Akhapkina
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: elena.akhapkins@gmail.com
ORCID iD: 0000-0002-5874-0082
Employee
Russian Federation, MoscowDmitriy N. Degtyarev
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Sechenov First Moscow State Medical University (Sechenov University)
Email: d_degtiarev@oparina4.ru
ORCID iD: 0000-0001-8975-2425
Sci. (Med.), Prof., neonatologist
Russian Federation, Moscow; MoscowReferences
- Ellington TD, Miller JW, Henley SJ, et al. Trends in breast cancer incidence, by race, ethnicity, and age among women aged ≥20 Years – United States, 1999-2018. MMWR Morb Mortal Wkly Rep. 2022;71(2):43-7. doi: 10.15585/mmwr.mm7102a2
- Di Mattei VE, Perego G, Taranto P, et al. Psychological issues in breast cancer survivors confronted with motherhood: Literature review and a call to action. Front Psychol. 2023;14:1133204. doi: 10.3389/fpsyg.2023.1133204
- Lambertini M, Di Maio M, Poggio F, et al. Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in young BRCA-mutated breast cancer patients. Reprod Biomed Online. 2019;38(5):835-44. doi: 10.1016/j.rbmo.2018.11.031
- Galati F, Magri V, Arias-Cadena PA, et al. Pregnancy-associated breast cancer: A diagnostic and therapeutic challenge. Diagnostics (Basel). 2023;13(4):604. doi: 10.3390/diagnostics13040604
- Shanmugam S, Balakrishnan S. Association of breast feeding in ovarian malignancy: Is breastfeeding a boon? A single institutional experience. Int J Reprod Contracept Obstet Gynecol. 2023;12(6):1666-9.
- Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am. 2012;26(1):1-12. doi: 10.1016/j.hoc.2011.10.009
- Holman DA. Fertility preservation in gynecologic cancer. Semin Oncol Nurs. 2019;35(2):202-10. doi: 10.1016/j.soncn.2019.02.007
- Юпатов Е.Ю., Курманбаев Т.Е., Шмидт А.А., и др. Криоконсервация репродуктивной ткани – возможность сохранения фертильности (обзор литературы). Проблемы репродукции. 2020;26(5):99-106 [Yupatov EYu, Kurmanbaev TE, Shmidt AA, et al. Cryopreservation of reproductive tissue – the possibility of preserving fertility (a review). Russian Journal of Human Reproduction. 2020;26(5):99-106 (in Russian)]. doi: 10.17116/repro20202605199
- Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016;101(4):1364-71. doi: 10.1210/jc.2015-3878
- Lakhoo K, Davies J, Chakraborty S, et al. Development of a new reproductive tissue cryopreservation clinical service for children: The Oxford programme. Pediatr Surg Int. 2019;35(11):1271-8. doi: 10.1007/s00383-019-04503-3
- Jordan SJ, Cushing-Haugen KL, Wicklund KG, et al. Breast feeding and risk of epithelial ovarian cancer. Cancer Causes Control. 2012;23(6):919-27. doi: 10.1007/s10552-012-9963-4
- Babic A, Sasamoto N, Rosner BA, et al. Association between breastfeeding and ovarian cancer risk. JAMA Oncol. 2020;6(6):e200421. doi: 10.1001/jamaoncol.2020.0421
- Bhurosy T, Niu Z, Heckman CJ. Breastfeeding is possible: A systematic review on the feasibility and challenges of breastfeeding among breast cancer survivors of reproductive age. Ann Surg Oncol. 2021;28(7):3723-35. doi: 10.1245/s10434-020-09094-1
- Dagla M, Mrvoljak-Theodoropoulou I, Karagianni D, et al. Women’s mental health as a factor associated with exclusive breastfeeding and breastfeeding duration: Data from a Longitudinal Study in Greece. Children (Basel). 2021;8(2):150. doi: 10.3390/children8020150
- Johnson HM, Mitchell KB; Academy of Breastfeeding Medicine. ABM Clinical Protocol #34: Breast cancer and breastfeeding. Breastfeed Med. 2020;15(7):429-34. doi: 10.1089/bfm.2020.29157.hmj
- Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiation-induced changes in the breast. Hum Pathol. 1984;15(6):545-50. doi: 10.1016/s0046-8177(84)80008-8
- Leal SC, Stuart SR, Carvalho Hde A. Breast irradiation and lactation: A review. Expert Rev Anticancer Ther. 2013;13(2):159-64. doi: 10.1586/era.12.178
- Duffy C, Cyr M. Phytoestrogens: Potential benefits and implications for breast cancer survivors. J Womens Health (Larchmt). 2003;12(7):617-31. doi: 10.1089/154099903322404276
- Lambertini M, Blondeaux E, Bruzzone M, et al. Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2021;39(29):3293-305. doi: 10.1200/JCO.21.00535
- Partridge A, Pagani O, Niman S, et al. abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13). Cancer Research. 2023;83(5 Suppl.): GS4-09-GS4-09. doi: 10.1158/1538-7445.SABCS22-GS4-09
- Ogg S, Klosky JL, Chemaitilly W, et al. Breastfeeding practices among childhood cancer survivors. J Cancer Surviv. 2020;14(4):586-99. doi: 10.1007/s11764-020-00882-y
- Haliloglu N, Ustuner E, Ozkavukcu E. Breast ultrasound during lactation: Benign and malignant lesions. Breast Care (Basel). 2019;14(1):30-4. doi: 10.1159/000491781
- Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics. 2007;27(Suppl. 1):S101-24. doi: 10.1148/rg.27si075505
- di Florio-Alexander RM, Slanetz PJ, Moy L, et al.; Expert Panel on Breast Imaging. ACR Appropriateness Criteria® breast imaging of pregnant and lactating women. J Am Coll Radiol. 2018;15(11S):S263-75. doi: 10.1016/j.jacr.2018.09.013
- Chung M, Ruiz-Cordero R, Lee AY, et al. MRI evaluation of the lactating breast. Curr Radiol Rep. 2022;10(5):57-67. doi: 10.1007/s40134-022-00395-9
- Lo AC, Ronckers C, Aznar MC, et al. Breast hypoplasia and decreased lactation from radiation therapy in survivors of pediatric malignancy: A PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2021:S0360-3016(21)02725-5. doi: 10.1016/j.ijrobp.2021.08.032
- Wheeler G, Grassberger C, Samers J, et al. Central endocrine complications among childhood cancer survivors treated with radiation therapy: A PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2023:S0360-3016(23)00416-9. doi: 10.1016/j.ijrobp.2023.04.024
- Radiotherapy. In: Drugs and Lactation Database (LactMed®). Bethesda (MD): National Institute of Child Health and Human Development, 2006. Available at: https://pubmed.ncbi.nlm.nih.gov/30000783/ Accessed: 30.07.2023.
- Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? Cancer Treat Rev. 2013;39(3):207-11. doi: 10.1016/j.ctrv.2012.10.002
- Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: Time to unify the approach. J Hum Lact. 2002;18(4):323-32. doi: 10.1177/089033402237904
- Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy. Oncologist. 2017;22(3):324-34. doi: 10.1634/theoncologist.2016-0208
- Sella T, Sorouri K, Rosenberg Sh, et al. abstract P5-08-06: Breastfeeding in survivors of early breast cancer. Cancer Research. 2023;83: P5-08. doi: 10.1158/1538-7445.SABCS22-P5-08-06
- Linkeviciute A, Notarangelo M, Buonomo B, et al. Breastfeeding after breast cancer: Feasibility, Safety, and ethical perspectives. J Hum Lact. 2020;36(1):40-3. doi: 10.1177/0890334419887723
- Vandenbroucke T, Verheecke M, van Gerwen M, et al. Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy. Eur J Cancer. 2020;138:57-67. doi: 10.1016/j.ejca.2020.07.004
- Schwarz EB, Hess R, Trussell J. Contraception for cancer survivors. J Gen Intern Med. 2009;24(Suppl. 2):S401-6. doi: 10.1007/s11606-009-1023-8
- Юрова М.В., Межевитинова Е.А., Якушевская О.В., и др. Влияние гормональной контрацепции на риск развития рака молочной железы. Современная Онкология. 2023;25(2):199-207 [Iurova MV, Mezhevitinova EA, Yakushevskaya OV, et al. The effect of hormonal contraception on the risk of breast cancer: A review. Journal of Modern Oncology. 2023;25(2):199-207 (in Russian)]. doi: 10.26442/18151434.2023.2.202287
- FSRH Guideline Contraception After Pregnancy. Faculty of Sexual & Reproductive Healthcare, 2020. Available at: https://www.fsrh.org/standards-and-guidance/documents/contraception-after-pregnancy-guideline-january-2017/ Accessed: 30.07.2023.
- Чернуха Г.Е., Пронина В.А. Низкодозированная внутриматочная контрацепция – инновационный подход к профилактике нежелательной беременности. Медицинский совет. 2022;16(5):40-5 [Chernukha GE, Pronina VA. Low-dose intrauterine contraception is an innovative approach to the prevention of unwanted pregnancy. Meditsinskiy Sovet. 2022;16(5):40-5 (in Russian)]. doi: 10.21518/2079-701X-2022-16-5-40-45